On June 29, 2026, AeroVironment (NASDAQ: AVAV) released its financial results for the fourth quarter and full year of fiscal 2026. Following the announcement, the stock surged in after-hours trading, with gains exceeding 20%. The rally continued the next day, with intraday gains expanding to 23%. By the close on June 30, AVAV settled at $165.07, marking a single-day increase of 18.76%.
Headquartered in Virginia, this defense technology company specializes in unmanned aerial systems, loitering munitions, counter-drone technologies, space and cyber warfare capabilities, and directed energy weapons. Its core products include the Switchblade series of loitering munitions, Puma and Raven reconnaissance drones, and the LOCUST laser weapon system.
The market’s strong reaction to AVAV’s earnings release wasn’t just about the impressive numbers—it also touched on several key issues shaping the global defense tech industry: How are geopolitical conflicts reshaping military procurement strategies? Which technology segments will benefit from structural increases in defense budgets? What is the growth ceiling for a defense contractor deeply embedded in the U.S. military supply chain?
How Strong Are the Numbers?
In Q4 of fiscal 2026, AeroVironment posted revenue of $641.6 million, up 133% year-over-year and significantly beating the consensus estimate of about $558 million. Full-year revenue reached $1.977 billion, up 141% from the previous year.
Profitability also exceeded market expectations. Non-GAAP adjusted earnings per share for the quarter came in at $1.84, about 25% above the analyst estimate of $1.47. On a GAAP basis, quarterly net income was $63.2 million, nearly a 280% increase year-over-year.
Growth was driven by multiple factors. First, the acquisition of BlueHalo in May 2025 and ESAero in March 2026 contributed more than $282 million in revenue for the quarter. Even excluding these acquisitions, organic growth remained strong at 31%. Second, the Autonomous Systems (AxS) segment generated $492.4 million in revenue, accounting for 76% of total company sales. Within this segment, precision strike and defense (including the Switchblade, Red Dragon, and Titan product lines) brought in $333 million, up 80% year-over-year.
Looking at the year-over-year base, Q4 fiscal 2025 revenue was $275 million, meaning AVAV more than doubled its revenue scale over the past year.
Reconciling Order Backlog and Earnings Guidance
One data point in the earnings report stands out even more than current revenue—orders. Total bookings for fiscal 2026 reached $2.7 billion, with a book-to-bill ratio of 1.4, indicating that new orders are growing much faster than revenue recognition. By the end of the reporting period, funded backlog (orders with allocated funding) hit $1.2 billion, up 65% year-over-year.
The rapid growth in orders reflects robust end-market demand. Orders for counter-drone systems and laser weapons doubled. In June 2026, the U.S. Army awarded AeroVironment a $117 million contract to procure 82 P550 drone systems. That same month, the company secured a $20 million contract from the U.S. Air Force Research Laboratory for aerospace ceramic materials. In May, the U.S. Army selected Switchblade 400 as a key component of the LASSO program.
However, the company’s guidance for fiscal 2027 fell short of market expectations. Management projects revenue of $2.13 billion to $2.23 billion, with non-GAAP adjusted EPS between $3.02 and $3.34. Notably, the earnings guidance is well below the prior market consensus of $3.85 to $4.00.
The lower guidance is due to a significant increase in capital expenditures. The company plans to raise capex as a percentage of revenue from 5% in fiscal 2026 to 12–14% in fiscal 2027, aimed at expanding production capacity for Switchblade missiles and laser weapons. This is expected to increase depreciation and amortization expenses by about $37 million. Additionally, the cancellation of the SCAR contract and the natural decline in Ukraine-related revenue each represent roughly 5% headwinds.
The market’s response is telling—investors clearly value order momentum over short-term profit guidance. The $1.2 billion backlog provides revenue visibility for the next 12–18 months, and increased capex is viewed as necessary upfront investment to meet structural demand.
How Structural Expansion in Global Defense Spending Impacts AVAV
AVAV’s explosive growth is not an isolated event—it’s part of a broader macro narrative. Global defense spending is undergoing its most significant expansion cycle since the end of the Cold War.
According to Forecast International, global defense expenditures will exceed $2.6 trillion in 2026, up 8.1% from 2025. The U.S. alone is set to reach a historic high of about $1 trillion in defense budget for fiscal 2026. Drivers behind this surge include the ongoing Russia-Ukraine war, accelerating U.S.-China strategic competition, and spreading regional instability.
This wave of military spending shows clear structural trends. Procurement of traditional manned platforms (tanks, fighter jets, warships) is slowing, while unmanned systems, precision-guided munitions, counter-drone technologies, and space capabilities are capturing a growing share of budgets.
The military drone market is projected to grow from $34.85 billion in 2026 to $109.22 billion in 2031, with a compound annual growth rate (CAGR) of 25.7%. The counter-drone systems market will reach $12.6 billion in 2026 and is expected to grow to $24.1 billion by 2030. The directed energy weapons market is forecast to rise from about $4.58 billion in 2026 to $12.11 billion by 2035.
AeroVironment’s product portfolio covers these three fastest-growing segments. CEO Wahid Nawabi stated during the earnings call that recent global geopolitical conflicts have fundamentally reshaped the nature of warfare, and demand for drones, counter-drone, and space technologies is reaching a structural inflection point. He noted that the U.S. Department of Defense’s annual drone budget alone is expected to exceed $75 billion next year.
Controversies and Risks: The Dark Side of High-Growth Narratives
Every high-growth story has another side. AVAV’s stock had fallen more than 42% from the start of 2026 until the earnings rebound. This decline reflects the market’s pricing of multiple risks.
First, there are issues with financial restatements and internal controls. The company previously restated its financials due to the cancellation of the SCAR contract and disclosed significant deficiencies in internal controls. A securities fraud class action has been filed regarding statements about the SCAR contract.
Second, there’s customer concentration risk. AVAV’s revenue is highly dependent on procurement decisions by the U.S. Department of Defense and its allies. Any budget cuts, project cancellations, or shifts in procurement priorities could have a major impact on performance. The SCAR contract cancellation already illustrated this risk.
Third, there’s execution risk in capacity expansion. The company plans to significantly increase capex over the next year, which is both a prerequisite for growth and a source of short-term profit pressure. The speed of expansion, cost control, and utilization of new capacity all carry uncertainty.
Fourth, there’s valuation divergence. Despite the stock’s sharp pullback from its highs, institutional price targets for AVAV vary widely. Wedbush set a target price of $250, Stifel lowered its target to $220, and Barchart’s consensus median target is about $295. Target price ranges span from $172 to $400.
Institutional Views: Consensus and Divergence
Despite these risks, Wall Street’s overall rating for AVAV remains optimistic. Zacks rates AVAV as Level 3 (Hold), while Barchart’s institutional consensus is "Strong Buy."
Wedbush issued an "Outperform" rating after the earnings release, with a $250 target price, citing the company’s cross-domain capabilities across air, land, sea, space, and cyber as a durable competitive advantage. Wedbush’s analysts acknowledge recent pressures from financial restatements and contract cancellations, but argue these factors create more attractive valuations for investors seeking exposure to next-generation defense technologies. The firm emphasized that AVAV’s battle-tested products "form a lasting moat that new entrants cannot replicate within the relevant time frame."
Stifel maintained a Buy rating but lowered its target price from $315 to $220, mainly due to the dilutive effect of rising capex on short-term profits. Stifel’s valuation is based on 30 times fiscal 2028 EBITDA.
Notably, despite generally positive institutional ratings, AVAV’s stock has dropped 51% over the past year and currently trades near its 52-week low of $135.20. This suggests the market has already priced in much of the negative news, and the earnings beat may signal a fundamental turning point.
Investment Framework for Defense Tech Assets: Lessons from AVAV
AVAV’s case provides a framework for analyzing defense technology assets.
The first dimension is order visibility. Unlike traditional commercial companies, defense contractors’ revenue depends heavily on government contract timelines and funding cycles. Thus, backlog—especially funded backlog—offers a more accurate reflection of real demand than current revenue. AVAV’s $1.2 billion funded backlog gives more than 12 months of revenue visibility, which is a key support for its valuation.
The second dimension is the alignment of product portfolio with defense budget structure. AVAV’s drones, loitering munitions, counter-drone, and laser weapons cover the fastest-growing segments of defense budgets. This structural match determines whether the company can continue to benefit from military spending expansion over the medium to long term.
The third dimension is the relationship between M&A integration and organic growth. AVAV achieved step-change growth through acquisitions of BlueHalo and ESAero, but M&A also brings integration risks, goodwill impairment, and financial restatement issues. Investors need to distinguish between sustainable organic growth and one-off M&A contributions.
The fourth dimension is the mismatch between capex cycles and profit cycles. Defense tech companies often need to invest heavily in capacity ahead of demand surges, which suppresses profit margins in the short term but lays the foundation for long-term growth. AVAV is currently in this stage, and the market’s response to its profit guidance will depend on how much premium investors are willing to pay for future growth.
Conclusion
AeroVironment’s fiscal 2026 earnings report paints a classic picture of a defense technology company in a cycle of structural demand expansion: rapid growth in revenue and orders, capacity expansion weighing on short-term profits, and valuation tug-of-war between optimism and caution. The core investment thesis rests on the long-term global trend toward unmanned systems and directed energy weapons, while short-term risks stem from customer concentration, contract execution uncertainty, and profit dilution from capacity investments. AVAV’s future performance will depend on its ability to convert $1.2 billion in backlog into sustainable revenue growth and find a balance between capacity expansion and profit margins.
Frequently Asked Questions (FAQ)
Q1: What are AVAV’s main business lines?
AeroVironment is a defense technology company focused on autonomous systems (drones, loitering munitions, ground robots) as well as space, cyber, and directed energy segments. Its core products include the Switchblade series of loitering munitions, Puma and Raven reconnaissance drones, and the LOCUST laser weapon system.
Q2: How did AVAV perform in its latest financial report?
In the fourth quarter of fiscal 2026, the company posted revenue of $641.6 million, up 133% year-over-year; full-year revenue was $1.977 billion, up 141%. Non-GAAP adjusted EPS was $1.84, about 25% above analyst expectations.
Q3: What is AVAV’s order situation?
Total bookings for fiscal 2026 reached $2.7 billion, with a book-to-bill ratio of 1.4. By the end of the reporting period, funded backlog was $1.2 billion, up 65% year-over-year.
Q4: Why is AVAV’s earnings guidance below expectations?
The company expects fiscal 2027 revenue of $2.13–$2.23 billion, but profit guidance is below market expectations. The main reason is that capex will rise sharply from 5% to 12–14% of revenue to expand production capacity.
Q5: What are the main risks facing AVAV?
Key risks include: customer concentration in the U.S. Department of Defense, financial restatement and litigation related to the SCAR contract cancellation, execution risk in capacity expansion, and a market environment with wide valuation divergences.
Q6: How do institutions view AVAV?
Institutional ratings are generally optimistic, but target prices vary widely. Wedbush rates AVAV "Outperform" with a $250 target, Stifel maintains "Buy" but lowered its target to $220, and Barchart’s consensus median target is about $295.
